-
Sector Analysis
![]()
Green Bites – Key Disruptive Forces in Sustainable Nutrition
Disruptive Forces in Sustainable Nutrition Report Overview Advanced developments such as edible insects, food 3D printing, and plant-based proteins are redefining food efficiency and environmental impact in the sustainable nutrition domain. Innovation Curve: Consumer Buy the Full Report to Know More about the Disruptive Forces in Sustainable Nutrition Download a Free Report Sample The ‘Green Bites – Key Disruptive Forces in Sustainable Nutrition’ FutureTech series report categorizes the key innovation areas in sustainable nutrition as emerging, accelerating, and maturing. The...
-
Company Profile
![]()
Stichting Pensioenfonds ABP – Company Profile
Stichting Pensioenfonds ABP (ABP) offers pension fund and insurance services for employees in the government, public, and education sectors. The company offers a range of pension funds such as retirement and surviving dependents' benefits, disability or incapacity pensions, and flexible pensions. The company’s principal tasks in administration activities include asset management, pension administration, communication, and support services. ABP invests in government bonds, inflation-linked bonds, corporate bonds, alternative inflation, and equities and alternative investments including developed-market equities, emerging-market equities, real estate,...
Add to Basket -
Company Profile
![]()
Nordea Bank Abp – Company Profile
Nordea Bank Abp (Nordea), along with its subsidiaries, is a provider of a range of financial products and services. Its offerings include savings and currents accounts, consumer and personal loans, vehicle loans, overdrafts, payments and cards, corporate finance, trade finance services, investment management, structured products, investment funds, asset management, pension schemes, private banking, and life, health, and non-life insurance. The bank also offers international banking, Internet and telephone banking, online trading services, investment banking, foreign exchange, and money market, and...
Add to Basket -
Sector Analysis
![]()
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) – Global Drug Forecast and Market Analysis to 2025
Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident cases, approximately 85% are the non-small cell lung cancer (NSCLC) subtype. NSCLC patients are usually diagnosed in the later stages of the disease, with poor prognosis. Historically, treatment options for advanced-stage NSCLC patients have been dominated by chemotherapy. However, the launch of targeted therapies such as Iressa (gefitinib) in 2003, Tarceva (erlotinib) in 2004, and Xalkori (crizotinib) in 2011, has shifted...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.